Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke

NCT02586233 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke
Thrombotic Disease

Interventions

DRUG: DS-1040b
DRUG: Placebo

Sponsor

Daiichi Sankyo